BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14738710)

  • 1. Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase -2.
    Yáñez JA; Teng XW; Roupe KA; Fariss MW; Davies NM
    J Pharm Pharm Sci; 2003; 6(3):308-14. PubMed ID: 14738710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats.
    Bonin AM; Yáñez JA; Fukuda C; Teng XW; Dillon CT; Hambley TW; Lay PA; Davies NM
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):755-64. PubMed ID: 20035423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bile in pathogenesis of indomethacin-induced enteropathy.
    Jacob M; Foster R; Sigthorsson G; Simpson R; Bjarnason I
    Arch Toxicol; 2007 Apr; 81(4):291-8. PubMed ID: 17151867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of inhibition OF COX-2 and COX-3 in gastrointestinal damage induced by NSAID in rats ].
    Laudanno OM; San Miguel P; Aramberry LJ; Cesolari JA
    Acta Gastroenterol Latinoam; 2003; 33(4):183-5. PubMed ID: 14708469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
    Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
    J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution to safe anti-inflammatory therapy with indomethacin.
    Bauerová K; Nosál'ová V; Mihalová D; Navarová J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S8-10. PubMed ID: 15141962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions.
    Kim JH; Rhee HI; Jung IH; Ryu K; Jung K; Han CK; Kwak WJ; Cho YB; Joo HJ
    Life Sci; 2005 Jul; 77(11):1181-93. PubMed ID: 15935401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
    Hatazawa R; Ohno R; Tanigami M; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type and distribution of indomethacin-induced lesions in the gastrointestinal tract of rat.
    Kunes M; Kvetina J; Bures J
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():96-100. PubMed ID: 20027152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers.
    Davies NM; Jamali F
    Hum Exp Toxicol; 1997 Jul; 16(7):345-9. PubMed ID: 9257157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
    Menozzi A; Pozzoli C; Giovannini E; Solenghi E; Grandi D; Bonardi S; Bertini S; Vasina V; Coruzzi G
    Eur J Pharmacol; 2006 Dec; 552(1-3):143-50. PubMed ID: 17069793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of interleukin 18 in indomethacin-induced lesions of the gastric mucosa in adjuvant-induced arthritis rat.
    Nagai N; Fukuhata T; Ito Y; Usui S; Hirano K
    Toxicology; 2009 Jan; 255(3):124-30. PubMed ID: 18996434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early pathogenic events in NSAID-induced gastrointestinal damage.
    Bjarnason I; Hayllar J
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():19-22. PubMed ID: 9032577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytopreventative effects of Gynostemma pentaphyllum against acute Indomethacin-induced gastrointestinal and renal toxicity in rats.
    Hesse C; Razmovski-Naumovski V; Duke CC; Davies NM; Roufogalis BD
    Phytother Res; 2007 Jun; 21(6):523-30. PubMed ID: 17380554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
    Chen XH; Bai JY; Shen F; Bai AP; Guo ZR; Cheng GF
    Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.